What Happened?
Billerica, MA-based Quanterix Appointed Jennifer Liberi as Director Global Commercial Enablement and Learning
About the Company
Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company`s ultra-sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanterix` technology is designed to enable much earlier disease detection, better prognosis and precise treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Billerica, Massachusetts.
About the Person
Jennifer Liberi is Director Global Commercial Enablement and Learning at Quanterix. Previously, Jennifer held various senior HR leadership roles in the industry.
Info Source
News
Short Profile